over 2500 people
have chosen eloctate.*

Get to know the ELOCTATE Peers and see how ELOCTATE has impacted their lives.

*Data on file. Waltham, MA; Bioverativ Therapeutics Incorporated

Laith switched to an every-4-day ELOCTATE dosing schedule.

see laith's story

Jenny chose ELOCTATE for her son because of its extended half-life.

watch their story

An every-5-day* prophy regimen with ELOCTATE keeps Kenny on the road.

see kenny's story

ELOCTATE keeps DJ in rhythm with his infusion schedule.

see dj's story

Lane started an every-4-day dosing schedule on ELOCTATE then moved to every-5-day.*

see lane's story

After years of treating on-demand, Ryan switched to prophy with ELOCTATE.

see ryan's story

After decades of treating on-demand Craig transitioned to prophy with ELOCTATE.

see craig's story

Chet’s son Caleb gets the protection he needs on ELOCTATE, on and off the basketball court.

see their story

Jonathan switched from ADVATE® to ELOCTATE.

see jonathan's story

Note: These are personal accounts of ELOCTATE Peers. Please talk to your healthcare provider about whether ELOCTATE may be right for you. Individual results may vary.

*The recommended starting regimen is 50 IU/kg every 4 days as directed by your doctor. In children under 6 years of age, the recommended starting regimen is 50 IU/kg administered twice weekly. The regimen can be adjusted based on your body's individual response.

† ELOCTATE has been proven to help patients prevent bleeding episodes using a prophylaxis regimen.

ADVATE® [Antihemophilic Factor (Recombinant)] is a registered trademark of Baxalta Incorporated, a wholly owned, indirect subsidary of Shire plc.

Do you or someone you care about have experience on ELOCTATE? Become an ELOCTATE Peer

eloctate 101:
get the basics

learn more

interested in financial
assistance programs?

find out more

questions for your
doc about switching

get started

Got more questions? Contact your CoRe.

Community Relations and Education Managers (or CoRe, for short) live and work all across the United States. CoRe team members are nurses or parents, social workers or people with hemophilia. They're available to answer your questions, educate, or just to talk. Use our handy CoRe Locator to find the CoRe team member nearest you.

indications and important facts about eloctate 

what is the most important information I should know about ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein]? You should not use ELOCTATE if you are allergic to ELOCTATE or any of its other ingredients. Tell your healthcare provider if you have had an allergic reaction to any Factor VIII product prior to using ELOCTATE.
Allergic reactions may occur. Call your healthcare provider or emergency department right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash or hives.

indications and important facts about eloctate 

what is the most important information I should know about ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein]? You should not use ELOCTATE if you are allergic to ELOCTATE or any of its other ingredients. Tell your healthcare provider if you have had an allergic reaction to any Factor VIII product prior to using ELOCTATE.
Allergic reactions may occur. Call your healthcare provider or emergency department right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash or hives.

Your body can also make antibodies called "inhibitors" against ELOCTATE. This can stop ELOCTATE from working properly. Your healthcare provider may give you blood tests to check for inhibitors.


THE MOST COMMON SIDE EFFECTS OF ELOCTATE INCLUDE: headache, rash, joint pain, muscle pain and general discomfort. These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider for more information and about any side effect that bothers you or does not go away.


WHAT SHOULD I TELL MY HEALTHCARE PROVIDER BEFORE STARTING ELOCTATE?

Tell your healthcare provider about all your health conditions, including if you:

  • Have or have had any medical problems.
  • Are taking any prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal medicines.
  • Are pregnant or planning to become pregnant. It is not known if ELOCTATE may harm your unborn baby.
  • Are breastfeeding. It is not known if ELOCTATE passes into breast milk or if it can harm your baby.

AFTER STARTING ELOCTATE:

If your bleeding is not controlled and you experience a lack of clinical response to Factor VIII therapy, call your healthcare provider right away.

Medicines are sometimes prescribed for purposes other than those listed here. Do not use ELOCTATE for a condition for which it was not prescribed. Do not share ELOCTATE with other people, even if they have the same symptoms that you have.


ELOCTATE INDICATIONS

ELOCTATE is an injectable medicine that is used to help control and prevent bleeding in people with Hemophilia A (congenital Factor VIII deficiency).

Your healthcare provider may give you ELOCTATE when you have surgery.


HOW SHOULD I RECEIVE ELOCTATE?

ELOCTATE should be administered as ordered by your healthcare provider. You should be trained on how to do infusions by your healthcare provider. Many people with hemophilia A learn to infuse ELOCTATE by themselves or with the help of a family member. See the booklet called "Instructions for Use" packaged in your ELOCTATE for directions on infusing. If you are unsure of the procedure, please ask your healthcare provider.


IMPORTANT FACTS ABOUT ELOCTATE

Please read this information carefully before using ELOCTATE and each time you get a refill, as there may be new information. This information does not take the place of talking with your healthcare provider about your medical condition or your treatment.


QUESTIONS?

The risk information provided here is not comprehensive. To learn more, talk about ELOCTATE with your healthcare provider or pharmacist.
The FDA-approved product labeling can be found at www.eloctate.com or 1-855-MyELOCTATE (693-5628). You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.


MANUFACTURED BY

Bioverativ Therapeutics Inc.
Waltham, MA 02451 USA
U.S. License #2078


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.


Please see Full Prescribing Information